A phase 2 study of the oral vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, rivoceranib, for recurrent or metastatic (R/M) adenoid cystic carcinoma (ACC).

被引：0
|
作者：
Kang, Hyunseok
Ahn, Myung-Ju
Muzaffar, Jameel
Keam, Bhumsuk
Bowles, Daniel W.
Wong, Deborah J. L.
Ho, Alan Loh
Kim, Sung-Bae
Worden, Francis P.
Yun, Tak
Sari, Suha
Conlan, Maureen G.
Hanna, Glenn J.
机构：
[1] UCSF Helen Diller Family Comprehens Canc Ctr, Hematol Oncol, San Francisco, CA USA
[2] Sungkyunkwan Univ Sch Med, Samsung Med Ctr, Seoul, South Korea
[3] H Lee Moffitt Canc Ctr & Res Inst, Head & Neck & Endocrine Oncol, Tampa, FL USA
[4] Seoul Natl Univ Hosp, Seoul, South Korea
[5] Univ Colorado Canc Ctr, Div Med Oncol, Aurora, CO USA
[6] Univ Calif Los Angeles, Los Angeles, CA USA
[7] Mem Sloan Kettering Canc Ctr, Head & Neck Serv, Div Solid Tumor Oncol, New York, NY USA
[8] Univ Ulsan Coll Med, Asan Med Ctr, Seoul, South Korea
[9] Univ Michigan, Rogel Canc Ctr, Endocrine Oncol Clin, Ann Arbor, MI USA
[10] Natl Canc Ctr, Ctr Specif Organs Canc, Rare Cancers Clin, Goyang Si, Gyeonggi Do, South Korea
[11] Elevar Therapeut, Salt Lake City, UT USA
[12] Dana Farber Canc Inst, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6020
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) Blockade as New Therapeutic Opportunity for Polycystic Kidney Disease
    Nunez-Gonzalez, Laura
    Tejedor, Lucia
    Pereira Hernandez, Maria
    Barcia De la Iglesia Ana
    Cordido, Adrian
    Garcia-Gonzalez, Miguel A.
    Ruiz-Ortega, Marta
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [22] Phase II study of lapatinib in recurrent or metastatic epidermal growth factor receptor and/or erbB2 expressing adenoid cystic carcinoma and non-adenoid cystic carcinoma malignant tumors of the salivary glands
    Agulnik, Mark
    Cohen, Ezra W. E.
    Cohen, Roger B.
    Chen, Eric X.
    Vokes, Everett E.
    Hotte, Sebastien J.
    Winquist, Eric
    Laurie, Scott
    Hayes, D. Neil
    Dancey, Janet E.
    Brown, Shirley
    Pond, Gregory R.
    Lorimer, Ian
    Daneshmand, Manijeh
    Ho, James
    Tsao, Ming-Sound
    Siu, Lillian L.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (25) : 3978 - 3984
  • [23] Stylopine: A potential natural metabolite to activate vascular endothelial growth factor receptor 2 (VEGFR2) in osteosarcoma therapy
    Velayutham, Naveen Kumar
    Thamaraikani, Tamilanban
    Wahab, Shadma
    Khalid, Mohammad
    Ramachawolran, Gobinath
    Abullais, Shahabe Saquib
    Wong, Ling Shing
    Sekar, Mahendran
    Gan, Siew Hua
    Ebenezer, Angel Jemima
    Ravikumar, Mrinalini
    Subramaniyan, Vetriselvan
    Mat Rani, Nur Najihah Izzati
    Wu, Yuan Seng
    Jeyabalan, Srikanth
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [24] Involvement Of Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) In Oxidized Phospholipid-Mediated Control Of Endothelial Barrier Function
    Zebda, N.
    Ho, T.
    Moldobaeva, N.
    Birukova, A.
    Berliner, J. A.
    Birukov, K. G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [25] The Evaluation of Vascular Endothelial Growth Factor A (VEGFA) and VEGFR2 Receptor as Prognostic Biomarkers in Bladder Cancer
    El Azzouzi, Meryem
    El Ahanidi, Hajar
    Hafidi Alaoui, Chaimae
    Chaoui, Imane
    Benbacer, Laila
    Tetou, Mohammed
    Hassan, Ilias
    Bensaid, Mounia
    Oukabli, Mohamed
    Ameur, Ahmed
    Al Bouzidi, Abderrahmane
    Attaleb, Mohammed
    El Mzibri, Mohammed
    DIAGNOSTICS, 2023, 13 (08)
  • [26] Quantitation of VEGFR2 (vascular endothelial growth factor receptor) inhibitors - review of assay methodologies and perspectives
    Sharma, Kuldeep
    Suresh, P. S.
    Mullangi, Ramesh
    Srinivas, N. R.
    BIOMEDICAL CHROMATOGRAPHY, 2015, 29 (06) : 803 - 834
  • [27] The Antifungal Drug Itraconazole Inhibits Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) Glycosylation, Trafficking, and Signaling in Endothelial Cells
    Nacev, Benjamin A.
    Grassi, Paola
    Dell, Anne
    Haslam, Stuart M.
    Liu, Jun O.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (51) : 44045 - 44056
  • [28] Procyanidin B2 inhibits angiogenesis and cell growth in oral squamous cell carcinoma cells through the vascular endothelial growth factor (VEGF)/VEGF receptor 2 (VEGFR2) pathway
    Sun, Qiurong
    Zhang, Taiyang
    Xiao, Qingchun
    Mei, Bingxin
    Zhang, Xingwang
    BIOENGINEERED, 2022, 13 (03) : 6500 - 6508
  • [29] Axitinib plus avelumab for recurrent/metastatic adenoid cystic carcinoma (R/M ACC): Biomarker analysis of the phase II trial
    Hoff, Camilla Oliveira
    McGrail, Daniel
    Mitani, Yoshitsugu
    Heeke, Simon
    Sousa, Luana
    Santos, Erison
    Siqueira, Juliana Mota
    Li, Kaiyi
    Bell, Diana
    Marques-Piubelli, Mario L.
    Lin, Shiaw-Yih
    El-Naggar, Adel K.
    Ferrarotto, Renata
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [30] In vivo imaging of vascular endothelial growth factor receptor-2 (VEGFR2) expression using biparatopic affibody construct
    Mitran, Bogdan
    Guler, Rezan
    Roche, Frank
    Lindstrom, Elin
    Fleetwood, Filippa
    Claesson-Welsh, Lena
    Selvaraju, Ram Kumar
    Tolmachev, Vladimir
    Stahl, Stefan
    Lofblom, John
    Orlova, Anna
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2017, 60 : S178 - S178
12345